Skip to main content

Up to date, approved and regulated prescribing and patient information for licensed medicines

Latest medicine updates

Mayzent 2 mg film-coated tablets

Active ingredients/generics: siponimod fumaric acid

Novartis Pharmaceuticals UK Ltd

Mayzent 0.25 mg film-coated tablets

Active ingredients/generics: siponimod fumaric acid

Novartis Pharmaceuticals UK Ltd

Ropivacaine 10 mg / ml solution for injection

Active ingredients/generics: ropivacaine hydrochloride

Sintetica Limited

Ibugel Forte 10%

Active ingredients/generics: ibuprofen

Dermal Laboratories Limited

Ibuleve Maximum Strength Gel 50g

Active ingredients/generics: ibuprofen

Diomed Developments Limited

Ibuleve Maximum Strength Gel 30g

Active ingredients/generics: ibuprofen

Diomed Developments Limited

Ximaract 50 mg powder for solution for injection

Active ingredients/generics: cefuroxime sodium

Bausch & Lomb U.K Limited

Ximaract 50 mg powder for solution for injection

Active ingredients/generics: cefuroxime sodium

Bausch & Lomb U.K Limited

Prozac 20mg per 5ml Oral Liquid

Active ingredients/generics: fluoxetine hydrochloride

Eli Lilly and Company Limited

More medicine updates

Useful links

Drug Safety Update

Latest drug safety advice for prescribers and medicine users, direct from the UK medicines' regulator – the MHRA

Yellow Card

Use the MHRA Yellow Card scheme to report any suspected problems or incidents with healthcare products and devices, as well as reporting side effects to medicines

Search dm+d browser

Find the latest NHS prices, pack sizes and manufacturers on the NHS dictionary of medicines and devices (dm+d)

X-PIL

X-PILs are Patient Information Leaflets (PILs) that have been specifically created for people with sight problems. Where available, they can be found on the Patient Leaflet tab for a medicine.

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue

Find out more here.